231 related articles for article (PubMed ID: 15646813)
1. Antimicrobial activity of phenothiazines.
Amaral L; Viveiros M; Molnar J
In Vivo; 2004; 18(6):725-31. PubMed ID: 15646813
[TBL] [Abstract][Full Text] [Related]
2. The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co-infected AIDS patient.
Viveiros M; Martins M; Couto I; Kristiansen JE; Molnar J; Amaral L
In Vivo; 2005; 19(4):733-6. PubMed ID: 15999542
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
Cunha BA
Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
[TBL] [Abstract][Full Text] [Related]
4. Reversal of resistance in microorganisms by help of non-antibiotics.
Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H
J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708
[TBL] [Abstract][Full Text] [Related]
5. Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump.
Kristiansen MM; Leandro C; Ordway D; Martins M; Viveiros M; Pacheco T; Molnar J; Kristiansen JE; Amaral L
In Vivo; 2006; 20(3):361-6. PubMed ID: 16724671
[TBL] [Abstract][Full Text] [Related]
6. Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB.
Amaral L; Martins A; Molnar J; Kristiansen JE; Martins M; Viveiros M; Rodrigues L; Spengler G; Couto I; Ramos J; Dastidar S; Fanning S; McCusker M; Pages JM
In Vivo; 2010; 24(4):409-24. PubMed ID: 20668307
[TBL] [Abstract][Full Text] [Related]
7. Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro.
Kristiansen MM; Leandro C; Ordway D; Martins M; Viveiros M; Pacheco T; Kristiansen JE; Amaral L
Int J Antimicrob Agents; 2003 Sep; 22(3):250-3. PubMed ID: 13678829
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S11-9; discussion S64-73. PubMed ID: 16813977
[TBL] [Abstract][Full Text] [Related]
10. Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries.
Amaral L; Viveiros M; Kristiansen JE
Trop Med Int Health; 2001 Dec; 6(12):1016-22. PubMed ID: 11737839
[TBL] [Abstract][Full Text] [Related]
11. "Non-Antibiotics": alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries.
Amaral L; Viveiros M; Kristiansen JE
Curr Drug Targets; 2006 Jul; 7(7):887-91. PubMed ID: 16842219
[TBL] [Abstract][Full Text] [Related]
12. Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis.
Amaral L; Molnar J
Expert Rev Anti Infect Ther; 2012 Aug; 10(8):869-73. PubMed ID: 23030326
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines.
Viveiros M; Amaral L
Int J Antimicrob Agents; 2001 Mar; 17(3):225-8. PubMed ID: 11282269
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Tigecycline: first of a new class of antimicrobial agents.
Rose WE; Rybak MJ
Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
[TBL] [Abstract][Full Text] [Related]
16. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
17. Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy.
Amaral L; Kristiansen JE; Viveiros M; Atouguia J
J Antimicrob Chemother; 2001 May; 47(5):505-11. PubMed ID: 11328759
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
French GL
J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
[TBL] [Abstract][Full Text] [Related]
19. Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study.
Martins M; Bleiss W; Marko A; Ordway D; Viveiros M; Leandro C; Pacheco T; Molnar J; Kristiansen JE; Amaral L
In Vivo; 2004; 18(6):787-94. PubMed ID: 15646821
[TBL] [Abstract][Full Text] [Related]
20. Phenothiazines as a solution for multidrug resistant tuberculosis: From the origin to present.
Kristiansen JE; Dastidar SG; Palchoudhuri S; Roy DS; Das S; Hendricks O; Christensen JB
Int Microbiol; 2015 Mar; 18(1):1-12. PubMed ID: 26415662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
